To gain insight into the functional activity of ADAM17, we selected Nectin-4, HB-EGF and AREG as surrogate markers for ADAM17 activity and evaluated them as potential tumor markers for ovarian cancer. This evidence concerns the gene NECTIN4 and ovarian cancer.